OncoSenX Company

OncoSenX is a developer of transient gene therapies designed for solid tumors.

Last Funding Type: Seed
Headquarters: Seattle, Washington, United States
Founded Date: 2017
Investor Type: Seed
Last Funding Date: 2021
Total Funding: 11700000
Employee Number: 1-10
Estimated Revenue: $10M to $50M
Investors Number: 8
Industry: Biotechnology, Health Care